IB CEO talks about company USP
Michelle Boxall IB Communications CEO talks about what we do and why we're different!
IB Communications is a leading international communications agency specialising in healthcare and life sciences. We hold specific expertise in the biotech and biopharma sectors, including immunotherapy, regenerative medicine, ATMPs and cell and gene therapy.
IB Communications has developed a unique operating manual based on strategy, creativity and influence - all underpinned by a can-do work culture. We deliver for our clients an increase in profile and visibility through a variety of media to drive commercial value, support for business goals and the creation of awareness for science, products and services.
We build reputations that
Life science and biopharma markets are specialist fields that need specialist communicators with the right expertise.
IB Communications currently represents a wide variety of organizations within the field. This includes industry-leading societies, drug developers, CDMOs, CROs, supply chain services, raw and ancillary material suppliers, medical device companies, software developers, sector specialist international/national societies, groups and services.